Virax Biolabs Group Ltd (VRAX) Free cash flow 2024–2025
Virax Biolabs Group Ltd (VRAX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.2MFY2025 · since FY2024: -$7.2M → -$5.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.2M | +28.2% |
| FY2024 | -$7.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VRAX financial trends
VRAX RevenueVRAX Net incomeVRAX Net marginVRAX Gross profitVRAX Gross marginVRAX Operating incomeVRAX Operating marginVRAX Operating cash flowVRAX Capital expendituresVRAX Return on equityVRAX Stock buybacksVRAX Dividends paidVRAX Total assetsVRAX Total liabilitiesVRAX Shareholders’ equityVRAX overview →